This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Revolution Medicines, Inc., Wilmington Trust, National Association, as Agent. Active years: 2024-2026.
Company Filing History:
1 out of 40 
1 out of 3 Years Active: 2024-2026
Title: W Clay Gustafson: Innovator in Cancer Treatment
Introduction
W Clay Gustafson is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of methods utilizing mTOR inhibitors.
Latest Patents
Gustafson holds a patent for "Methods of treating cancer with an mTOR inhibitor." This patent outlines methods for treating diseases or disorders, particularly cancer, by administering specific dosages of mTOR inhibitors. The disclosure also includes strategies for delaying, preventing, or treating acquired resistance to RAS inhibitors, as well as methods for managing adverse events associated with mTOR inhibitor administration using tacrolimus.
Career Highlights
Gustafson is currently associated with Revolution Medicines, Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing effective treatment options for patients battling cancer.
Collaborations
Gustafson collaborates with esteemed colleagues, including Bojena Bitman and Ed Lorenzana, who contribute to the innovative environment at Revolution Medicines, Inc.
Conclusion
W Clay Gustafson's contributions to cancer treatment through his patent on mTOR inhibitors exemplify his commitment to advancing medical science. His work continues to inspire and pave the way for future innovations in cancer therapy.